Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Rescuers give up hope for the humpback whale stranded in the Baltic Sea - 2Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 3Los Angeles County sees significant uptick in norovirus cases, officials say
- 4CNN Crew Detained and Journalist Put in Chokehold in IDF Run-In: ‘We’re Journalists. What Are You Doing?!’
- 5Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- 4 well known subjects in school
- How Much Has the Iran War Cost the Average American Per Day?
- Ryan Gosling responds to Deidre Hall's invitation to visit the 'Days of Our Lives' set: 'This is a very enthusiastic yes'
- People with depression can treat themselves at home with new device
- In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- Brazil's former President Jair Bolsonaro seeks house arrest for prison time citing health issues
- Slims down for Maintainable Weight reduction
- Was it a stone tool or just a rock? An archaeologist explains how scientists can tell the difference
- Norovirus infections increase significantly, with positive test rates reaching 14%
